Clinical and Anatomical Characterization of Hypertrophic Cardiomyopathy.- Synopsis.- Hypertrophic Cardiomyopathy: An Overview.- Echocardiographic Identification of Patterns of Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy.- Distribution and Significance of Cardiac Muscle Cell Disorganization in the Left Ventricle of Patients with Hypertrophic Cardiomyopathy: Evidence of a Diffuse Cardiomyopathic Process.- Left Ventricular Biopsy in Hypertrophic Cardiomyopathy: Light and Electron Microscopic Evaluations.- Cardiomyopathy in Animals and Therapeutic Interventions.- Synopsis.- Spontaneously Occurring Hypertrophic Cardiomyopathy in Dogs and Cats: A Potential Animal Model of a Human Disease.- Cardiac Effects of Nerve Growth Factor in Dogs.- Prevention of Myocardial Cell Necrosis in the Syrian Hamster — Results of Long-Term Treatment.- Prevention by Verapamil of Isoproterenol-Induced Hypertrophic Cardiomyopathy in Rats.- Effects of Acute Administration of Verapamil in Patients with Hypertrophic Cardiomyopathy.- Synopsis.- Acute Hemodynamic Effects of Verapamil in Hypertrophic Cardiomyopathy.- Hemodynamics and Contractility After Oral, Intravenous, and Intracoronary Application of Calcium Antagonists.- Effect of Verapamil on Left Ventricular Isovolumic Relaxation Time and Regional Left Ventricular Filling in Hypertrophic Cardiomyopathy.- Treatment of Hypertrophic Cardiomyopathy with Verapamil.- Synopsis.- Verapamil Treatment of Hypertrophic Cardiomyopathy.- Volume Parameters of the Heart During Long-Term Verapamil Treatment in Patients with Hypertrophic Cardiomyopathy.- Long-Term Clinical Effects of Verapamil in Patients with Hypertrophic Cardiomyopathy.- Effects of Verapamil on Ventricular Wall Thickness of Patients with Hypertrophic Cardiomyopathy.- Long-Term Verapamil Treatment in Patients with Hypertrophic Nonobstructive Cardiomyopathy.- Verapamil: Its Potential for Causing Serious Complications in Patients with Hypertrophic Cardiomyopathy.- Long-Term Results of Different Therapeutic Interventions in Comparison with Verapamil.- Synopsis.- Efficacy of Operation for Obstructive Hypertrophic Cardiomyopathy: A 20-Year Experience with Ventricular Septal Myotomy and Myectomy.- Functional Results in Medically and Surgically Treated Patients with Hypertrophic Obstructive Cardiomyopathy.- Long-Term Treatment of Hypertrophic Cardiomyopathy with Verapamil or Propranolol. Preliminary Results of a Multicenter Study.- Effects of Different Calcium Blockers and Implications Regarding Therapy of Hypertrophic Cardiomyopathy.- Synopsis.- The Antianginal Efficacy of Seven Different Calcium Antagonists.- Differentiation of Calcium-Antagonistic Drugs with Respect to Their Myocardial Effects.- The Concept of Calcium Antagonist Therapy in Cardiac Hypertrophy. Different Calcium Antagonists with Respect to Therapeutic Efficacy in Hypertrophic Cardiomyopathy. Combined Therapy with Calcium Antagonists and Other Drugs?.- Clinical Pharmacology of Verapamil in Hypertrophic Cardiomyopathy.- Synopsis.- Pharmacokinetics, Bioavailability, and ECG Response of Verapamil in Man.- Verapamil Plasma Concentrations and Indices of Heart Size in Hypertrophic Obstructive Cardiomyopathy — Evidence for the Existence of a Therapeutic Range.- Plasma Verapamil Levels in Patients with Hypertrophic Cardiomyopathy: Interpatient Variability and Clinical Usefulness.- Correlation of Verapamil Plasma Levels with Electrocardiographic and Hemodynamic Effects.
